{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:58:57Z","timestamp":1786982337731,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hungarian Ministry of National Development","award":["#KMR-12-A FP7-HEALTH-2012-INNOVATION-1-Grant Agreement Number 306037"],"award-info":[{"award-number":["#KMR-12-A FP7-HEALTH-2012-INNOVATION-1-Grant Agreement Number 306037"]}]},{"name":"Hungarian National Research Foundation","award":["OTKA PD105019"],"award-info":[{"award-number":["OTKA PD105019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12253-020-00852-w","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T09:03:43Z","timestamp":1594199023000},"page":"2633-2640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increased miR-20b Level in High Grade Cervical Intraepithelial Neoplasia"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7373-8730","authenticated-orcid":false,"given":"T\u00edmea","family":"Szekercz\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m","family":"Galamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Benczik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn","family":"Kocsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Schlachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e1ndor","family":"\u00c1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsa","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Jeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Lendvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"852_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. \nhttps:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"852_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/jnci\/djt267","volume":"105","author":"M Safaeian","year":"2013","unstructured":"Safaeian M, Sherman ME (2013) From papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination. J Natl Cancer Inst 105:1524\u20131526. \nhttps:\/\/doi.org\/10.1093\/jnci\/djt267","journal-title":"J Natl Cancer Inst"},{"key":"852_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/labmed\/lmx080","volume":"49","author":"V Laengsri","year":"2018","unstructured":"Laengsri V, Kerdpin U, Plabplueng C, Treeratanapiboon L, Nuchnoi P (2018) Cervical Cancer markers: epigenetics and microRNAs. Lab Med 49:97\u2013111. \nhttps:\/\/doi.org\/10.1093\/labmed\/lmx080","journal-title":"Lab Med"},{"key":"852_CR4","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N, Forum Group Members, Bethesda 2001 Workshop (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287:2114\u20132119","journal-title":"JAMA"},{"key":"852_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"E Crosbie","year":"2013","unstructured":"Crosbie E, Einstein M et al (2013) Human papillomavirus and cervical cancer. Lancet 382:889\u2013899. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(13)60022-7","journal-title":"Lancet"},{"key":"852_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJF, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJLM (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383:524\u2013532. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(13)62218-7","journal-title":"Lancet"},{"key":"852_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(13)62028-0","volume":"383","author":"SD Isidean","year":"2014","unstructured":"Isidean SD, Franco EL (2014) Embracing a new era in cervical cancer screening. Lancet 383:493\u2013494. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(13)62028-0","journal-title":"Lancet"},{"key":"852_CR8","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","volume":"30","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, Ronco G, Anttila A, Meijer CJLM, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J (2012) Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30:F88\u2013F99. \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2012.06.095","journal-title":"Vaccine"},{"key":"852_CR9","doi-asserted-by":"publisher","first-page":"519619","DOI":"10.1155\/2013\/519619","volume":"2013","author":"ML Tornesello","year":"2013","unstructured":"Tornesello ML, Buonaguro L, Giorgi-Rossi P, Buonaguro FM (2013) Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. Biomed Res Int 2013:519619\u2013519610. \nhttps:\/\/doi.org\/10.1155\/2013\/519619","journal-title":"Biomed Res Int"},{"key":"852_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41379-019-0360-3","volume":"33","author":"I Nicol\u00e1s","year":"2020","unstructured":"Nicol\u00e1s I, Saco A, Barnadas E, Marimon L, Rakislova N, Fust\u00e9 P, Rovirosa A, Gaba L, Bu\u00f1esch L, Gil-Iba\u00f1ez B, Pahisa J, D\u00edaz-Feijoo B, Torne A, Ordi J, del Pino M (2020) Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix. Mod Pathol 33:128\u2013137. \nhttps:\/\/doi.org\/10.1038\/s41379-019-0360-3","journal-title":"Mod Pathol"},{"key":"852_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12253-014-9871-x","volume":"21","author":"\u00c1 Galamb","year":"2015","unstructured":"Galamb \u00c1, Benczik M, Zinner B, V\u00edgh E, Baghy K, Jeney C, Kiss A, Lendvai G, Sobel G (2015) Dysregulation of microRNA expression in human cervical preneoplastic and neoplastic lesions. Pathol Oncol Res Oncol Ogy Res 21:503\u2013508","journal-title":"Pathol Oncol Res Oncol Ogy Res"},{"key":"852_CR12","doi-asserted-by":"publisher","first-page":"e11780","DOI":"10.1371\/journal.pone.0011780","volume":"5","author":"PM Pereira","year":"2010","unstructured":"Pereira PM, Marques JP, Soares AR, Carreto L, Santos MAS (2010) Microrna expression variability in human cervical tissues. PLoS One 5:e11780. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0011780","journal-title":"PLoS One"},{"key":"852_CR13","first-page":"2561","volume":"33","author":"K Gocze","year":"2013","unstructured":"Gocze K, Gombos K et al (2013) Unique microRNA expression profiles in cervical cancer. Anticancer Res 33:2561\u20132568","journal-title":"Anticancer Res"},{"key":"852_CR14","first-page":"523","volume":"35","author":"K Gocze","year":"2015","unstructured":"Gocze K, Gombos K, Kovacs K, Juhasz K, Gocze P, Kiss I (2015) MicroRNA expressions in HPV-induced cervical dysplasia and cancer. Anticancer Res 35:523\u2013530","journal-title":"Anticancer Res"},{"key":"852_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ygyno.2016.07.093","volume":"142","author":"A Pedroza-Torres","year":"2016","unstructured":"Pedroza-Torres A, Fern\u00e1ndez-Retana J, Peralta-Zaragoza O, Jacobo-Herrera N, Cant\u00fa de Leon D, Cerna-Cort\u00e9s JF, Lopez-Camarillo C, P\u00e9rez-Plasencia C (2016) A microRNA expression signature for clinical response in locally advanced cervical cancer. Gynecol Oncol 142:557\u2013565. \nhttps:\/\/doi.org\/10.1016\/j.ygyno.2016.07.093","journal-title":"Gynecol Oncol"},{"key":"852_CR16","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/1878-0261.12383","volume":"12","author":"SS Liu","year":"2018","unstructured":"Liu SS, Chan KKL, Chu DKH, Wei TN, Lau LSK, Ngu SF, Chu MMY, Tse KY, Ip PPC, Ng EKO, Cheung ANY, Ngan HYS (2018) Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer. Mol Oncol 12:2009\u20132022. \nhttps:\/\/doi.org\/10.1002\/1878-0261.12383","journal-title":"Mol Oncol"},{"key":"852_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4590-4","volume":"18","author":"B Pardini","year":"2018","unstructured":"Pardini B, De Maria D et al (2018) MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer 18:1\u201317. \nhttps:\/\/doi.org\/10.1186\/s12885-018-4590-4","journal-title":"BMC Cancer"},{"key":"852_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-25310-1","volume":"8","author":"S Kawai","year":"2018","unstructured":"Kawai S, Fujii T, Kukimoto I, Yamada H, Yamamoto N, Kuroda M, Otani S, Ichikawa R, Nishio E, Torii Y, Iwata A (2018) Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia. Sci Rep 8:1\u201311. \nhttps:\/\/doi.org\/10.1038\/s41598-018-25310-1","journal-title":"Sci Rep"},{"key":"852_CR19","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.3892\/ol.2018.9323","volume":"16","author":"S Wang","year":"2018","unstructured":"Wang S, Chen X (2018) Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis. Oncol Lett 16:5200\u20135208. \nhttps:\/\/doi.org\/10.3892\/ol.2018.9323","journal-title":"Oncol Lett"},{"key":"852_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/ijc.30534","volume":"140","author":"A Kocsis","year":"2017","unstructured":"Kocsis A, Tak\u00e1cs T, Jeney C, Schaff Z, Koiss R, J\u00e1ray B, Sobel G, Pap K, Sz\u00e9kely I, Ferenci T, Lai HC, Ny\u00edri M, Benczik M (2017) Performance of a new HPV and biomarker assay in the management of hrHPV positive women: subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer. Int J Cancer 140:1119\u20131133. \nhttps:\/\/doi.org\/10.1002\/ijc.30534","journal-title":"Int J Cancer"},{"key":"852_CR21","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","volume":"64","author":"CL Andersen","year":"2004","unstructured":"Andersen CL, Jensen JL, \u00d8rntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and Colon Cancer data sets. Cancer Res 64:5245\u20135250. \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0496","journal-title":"Cancer Res"},{"key":"852_CR22","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.3892\/ol.2018.9363","volume":"16","author":"Y Yang","year":"2018","unstructured":"Yang Y, Liu Y, Li G, Li L, Geng P, Song H (2018) MicroRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2. Oncol Lett 16:5679\u20135686. \nhttps:\/\/doi.org\/10.3892\/ol.2018.9363","journal-title":"Oncol Lett"},{"key":"852_CR23","doi-asserted-by":"publisher","first-page":"9994","DOI":"10.3892\/ol.2018.8566","volume":"15","author":"R Chen","year":"2018","unstructured":"Chen R, Shi YH et al (2018) Systematic prediction of target genes and pathways in cervical cancer from microRNA expression data. Oncol Lett 15:9994\u201310000. \nhttps:\/\/doi.org\/10.3892\/ol.2018.8566","journal-title":"Oncol Lett"},{"key":"852_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","volume":"44","author":"H Dweep","year":"2011","unstructured":"Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk--database: prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes. J Biomed Inform 44:839\u2013847. \nhttps:\/\/doi.org\/10.1016\/j.jbi.2011.05.002","journal-title":"J Biomed Inform"},{"key":"852_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/PPO.0b013e318250c001","volume":"18","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM (2012) Causes and consequences of MicroRNA dysregulation. Cancer J (United States) 18:215\u2013222. \nhttps:\/\/doi.org\/10.1097\/PPO.0b013e318250c001","journal-title":"Cancer J (United States)"},{"key":"852_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles G, Clark NR, Ma\u2019ayan A (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14:128. \nhttps:\/\/doi.org\/10.1186\/1471-2105-14-128","journal-title":"BMC Bioinformatics"},{"key":"852_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/or.2015.4369","volume":"35","author":"V Gonz\u00e1lez-Quintana","year":"2016","unstructured":"Gonz\u00e1lez-Quintana V, Palma-Berr\u00e9 L et al (2016) MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (review). Oncol Rep 35:3\u201312. \nhttps:\/\/doi.org\/10.3892\/or.2015.4369","journal-title":"Oncol Rep"},{"key":"852_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0200717","volume":"13","author":"M Kori","year":"2018","unstructured":"Kori M, Arga KY (2018) Potential biomarkers and therapeutic targets in cervical cancer: insights from the meta-analysis of transcriptomics data within network biomedicine perspective. PLoS One 13:1\u201327. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0200717","journal-title":"PLoS One"},{"key":"852_CR29","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.4161\/cc.21278","volume":"11","author":"TH Cheung","year":"2012","unstructured":"Cheung TH, Man KNM, Yu MY, Yim SF, Siu NSS, Lo KWK, Doran G, Wong RRY, Wang VW, Smith DI, Worley Jr MJ, Berkowitz RS, Chung TKH, Wong YF (2012) Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 11:2876\u20132884. \nhttps:\/\/doi.org\/10.4161\/cc.21278","journal-title":"Cell Cycle"},{"key":"852_CR30","doi-asserted-by":"publisher","first-page":"109350","DOI":"10.1016\/j.cellsig.2019.109350","volume":"62","author":"H Xu","year":"2019","unstructured":"Xu H, Li W, Luo S, Yuan J, Hao L (2019) Adipose derived stem cells promote tumor metastasis in breast Cancer cells by stem cell factor inhibition of miR20b. Cell Signal 62:109350. \nhttps:\/\/doi.org\/10.1016\/j.cellsig.2019.109350","journal-title":"Cell Signal"},{"key":"852_CR31","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.3892\/mmr.2017.7231","volume":"16","author":"Y Cheng","year":"2017","unstructured":"Cheng Y, Geng L, Zhao L, Zuo P, Wang J (2017) Human papillomavirus E6-regulated microRNA-20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2. Mol Med Rep 16:5464\u20135470. \nhttps:\/\/doi.org\/10.3892\/mmr.2017.7231","journal-title":"Mol Med Rep"},{"key":"852_CR32","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/ijc.29618","volume":"138","author":"Y He","year":"2016","unstructured":"He Y, Lin J, Ding Y, Liu G, Luo Y, Huang M, Xu C, Kim TK, Etheridge A, Lin M, Kong D, Wang K (2016) A systematic study on dysregulated microRNAs in cervical cancer development. Int J Cancer 138:1312\u20131327. \nhttps:\/\/doi.org\/10.1002\/ijc.29618","journal-title":"Int J Cancer"},{"key":"852_CR33","doi-asserted-by":"publisher","unstructured":"Wang X., Tang S., le S.Y., Lu R., Rader J.S., Meyers C., Zheng Z.M. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth PLoS One 3 \nhttps:\/\/doi.org\/10.1371\/journal.pone.0002557","DOI":"10.1371\/journal.pone.0002557"},{"key":"852_CR34","doi-asserted-by":"publisher","first-page":"14655","DOI":"10.18632\/oncotarget.14738","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Zhang Z, Xiao Z, Lin Y, Luo T, Zhou Q, Zhang X (2017) Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer. Oncotarget 8:14655\u201314665. \nhttps:\/\/doi.org\/10.18632\/oncotarget.14738","journal-title":"Oncotarget"},{"key":"852_CR35","doi-asserted-by":"publisher","first-page":"12773","DOI":"10.3390\/ijms160612773","volume":"16","author":"LS Serv\u00edn-Gonz\u00e1lez","year":"2015","unstructured":"Serv\u00edn-Gonz\u00e1lez LS, Granados-L\u00f3pez AJ et al (2015) Families of microRNAs expressed in clusters regulate cell signaling in cervical cancer. Int J Mol Sci 16:12773\u201312790. \nhttps:\/\/doi.org\/10.3390\/ijms160612773","journal-title":"Int J Mol Sci"},{"key":"852_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3892\/ol.2015.3842","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang H et al (2016) MicroRNA-147 suppresses proliferation, invasion and migration through the AKT\/mTOR signaling pathway in breast cancer. Oncol Lett 11:405\u2013410. \nhttps:\/\/doi.org\/10.3892\/ol.2015.3842","journal-title":"Oncol Lett"},{"key":"852_CR37","doi-asserted-by":"publisher","first-page":"15834","DOI":"10.1002\/jcb.28854","volume":"120","author":"X Han","year":"2019","unstructured":"Han X, Li X, Zhao H, Zhou D, Sun B, Liu A, Zhang J, Cui Z, Ma X, Yuan L (2019) Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma. J Cell Biochem 120:15834\u201315843. \nhttps:\/\/doi.org\/10.1002\/jcb.28854","journal-title":"J Cell Biochem"},{"key":"852_CR38","doi-asserted-by":"publisher","unstructured":"Virtanen E., Pietil\u00e4 T., Nieminen P., Qian K., Auvinen E. (2016) Low expression levels of putative HPV encoded microRNAs in cervical samples. Springerplus 5 \nhttps:\/\/doi.org\/10.1186\/s40064-016-3524-3","DOI":"10.1186\/s40064-016-3524-3"},{"key":"852_CR39","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.1401430111","volume":"111","author":"X Wang","year":"2014","unstructured":"Wang X, Wang HK, Li Y, Hafner M, Banerjee NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, Tuschl T, Zheng ZM (2014) MicroRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A 111:4262\u20134267. \nhttps:\/\/doi.org\/10.1073\/pnas.1401430111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"852_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3892\/mmr.2019.10809","volume":"21","author":"Z Liu","year":"2020","unstructured":"Liu Z, Mao L, Wang L, Zhang H, Hu X (2020) MiR-218 functions as a tumor suppressor gene in cervical cancer. Mol Med Rep 21:209\u2013219. \nhttps:\/\/doi.org\/10.3892\/mmr.2019.10809","journal-title":"Mol Med Rep"},{"key":"852_CR41","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/OTT.S218043","volume":"12","author":"P Nan","year":"2019","unstructured":"Nan P, Niu Y, Wang X, Li Q (2019) MiR-29a function as tumor suppressor in cervical cancer by targeting sirt1 and predict patient prognosis. Onco Targets Ther 12:6917\u20136925. \nhttps:\/\/doi.org\/10.2147\/OTT.S218043","journal-title":"Onco Targets Ther"},{"key":"852_CR42","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e75","volume":"28","author":"W Jiang","year":"2017","unstructured":"Jiang W, Pan J-J, Deng YH, Liang MR, Yao LH (2017) Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer. J Gynecol Oncol 28:e75. \nhttps:\/\/doi.org\/10.3802\/jgo.2017.28.e75","journal-title":"J Gynecol Oncol"},{"key":"852_CR43","doi-asserted-by":"publisher","first-page":"68397","DOI":"10.18632\/ONCOTARGET.11722","volume":"7","author":"Y Su","year":"2016","unstructured":"Su Y, Xiong J, Hu J, Wei X, Zhang X, Rao L (2016) MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis. Oncotarget 7:68397\u201368411. \nhttps:\/\/doi.org\/10.18632\/ONCOTARGET.11722","journal-title":"Oncotarget"},{"key":"852_CR44","doi-asserted-by":"publisher","first-page":"116668","DOI":"10.1016\/j.lfs.2019.116668","volume":"232","author":"VK Varghese","year":"2019","unstructured":"Varghese VK, Shukla V, Jishnu PV, Kabekkodu SP, Pandey D, Sharan K, Satyamoorthy K (2019) Characterizing methylation regulated miRNA in carcinoma of the human uterine cervix. Life Sci 232:116668. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2019.116668","journal-title":"Life Sci"},{"key":"852_CR45","doi-asserted-by":"publisher","first-page":"188306","DOI":"10.1016\/j.bbcan.2019.08.001","volume":"1872","author":"F Berti","year":"2019","unstructured":"Berti F, Salviano-Silva A et al (2019) From squamous intraepithelial lesions to cervical cancer: circulating microRNAs as potential biomarkers in cervical carcinogenesis. Biochim Biophys Acta Rev Cancer 1872:188306. \nhttps:\/\/doi.org\/10.1016\/j.bbcan.2019.08.001","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-020-00852-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-020-00852-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-020-00852-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T10:25:24Z","timestamp":1599128724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-020-00852-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1007\/s12253-020-00852-w","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]},"assertion":[{"value":"6 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest with respect to the research, authorship, and\/or publication of this article.MB is an employee of Synlab Hungary Kft. and NEUMANN Diagnostics Ltd., AK is of the NEUMANN Diagnostics Ltd. CJ and NV were former employees of NEUMANN Diagnostics Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}